Nisoldipine Patent Expiration

Nisoldipine was first introduced by Covis Pharma Gmbh in its drug Sular on Feb 2, 1995. 3 different companies have introduced drugs containing Nisoldipine.


Nisoldipine Patents

Given below is the list of patents protecting Nisoldipine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sular US5626874 Controlled release pharmaceutical tablet having lenticular form Nov 30, 2014

(Expired)

Covis



Nisoldipine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Nisoldipine Generic API Manufacturers

Several generic applications have been filed for Nisoldipine. The first generic version for Nisoldipine was by Mylan Pharmaceuticals Inc and was approved on Jul 25, 2008. And the latest generic version is by Amta Labs Ltd and was approved on Apr 10, 2023.

Given below is the list of companies who have filed for Nisoldipine generic, along with the locations of their manufacturing plants worldwide.